Cargando…

Tau-mediated synaptic damage in Alzheimer’s disease

Synapses are the principal sites for chemical communication between neurons and are essential for performing the dynamic functions of the brain. In Alzheimer’s disease and related tauopathies, synapses are exposed to disease modified protein tau, which may cause the loss of synaptic contacts that cu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jadhav, Santosh, Cubinkova, Veronika, Zimova, Ivana, Brezovakova, Veronika, Madari, Aladar, Cigankova, Viera, Zilka, Norbert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter Open 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936631/ https://www.ncbi.nlm.nih.gov/pubmed/28123806 http://dx.doi.org/10.1515/tnsci-2015-0023

Ejemplares similares

Genetic Background Influences the Propagation of Tau Pathology in Transgenic Rodent Models of Tauopathy
por: Smolek, Tomas, et al.
Publicado: (2019)

Corrigendum: Genetic Background Influences the Propagation of Tau Pathology in Transgenic Rodent Models of Tauopathy
por: Smolek, Tomas, et al.
Publicado: (2020)

Who fans the flames of Alzheimer's disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways
por: Zilka, Norbert, et al.
Publicado: (2012)

Astrocytes Derived from Familial and Sporadic Alzheimer’s Disease iPSCs Show Altered Calcium Signaling and Respond Differently to Misfolded Protein Tau
por: Brezovakova, Veronika, et al.
Publicado: (2022)

Enriched environment ameliorates propagation of tau pathology and improves cognition in rat model of tauopathy
por: Mate, Veronika, et al.
Publicado: (2022)

Truncated tau deregulates synaptic markers in rat model for human tauopathy
por: Jadhav, Santosh, et al.
Publicado: (2015)

Risk factors for canine cognitive dysfunction syndrome in Slovakia
por: Katina, Stanislav, et al.
Publicado: (2016)

First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model
por: Kontsekova, Eva, et al.
Publicado: (2014)

Modeling of Tau-Mediated Synaptic and Neuronal Degeneration in Alzheimer's Disease
por: Jaworski, Tomasz, et al.
Publicado: (2010)

Identification of structural determinants on tau protein essential for its pathological function: novel therapeutic target for tau immunotherapy in Alzheimer’s disease
por: Kontsekova, Eva, et al.
Publicado: (2014)

Synthesis and Assessment of Novel Probes for Imaging Tau Pathology in Transgenic Mouse and Rat Models
por: McMurray, Lindsay, et al.
Publicado: (2021)

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
por: Wu, Moxin, et al.
Publicado: (2021)

Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain
por: DeVos, Sarah L., et al.
Publicado: (2018)

Dendritic/Post-synaptic Tau and Early Pathology of Alzheimer’s Disease
por: Yin, Xiaomin, et al.
Publicado: (2021)

A walk through tau therapeutic strategies
por: Jadhav, Santosh, et al.
Publicado: (2019)

Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer’s disease? From preclinical studies to the clinical trials
por: Basheer, Neha, et al.
Publicado: (2023)

Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease
por: Stozicka, Zuzana, et al.
Publicado: (2010)

Protein Tau: Prime Cause of Synaptic and Neuronal Degeneration in Alzheimer's Disease
por: Crespo-Biel, Natalia, et al.
Publicado: (2012)

Circuitry and Synaptic Dysfunction in Alzheimer's Disease: A New Tau Hypothesis
por: Mondragón-Rodríguez, Siddhartha, et al.
Publicado: (2020)

Trafficking of immune cells across the blood-brain barrier is modulated by neurofibrillary pathology in tauopathies
por: Majerova, Petra, et al.
Publicado: (2019)

A Survey of Intestinal Helminths of Dogs in Slovakia with an Emphasis on Zoonotic Species
por: Jarošová, Júlia, et al.
Publicado: (2021)

Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer’s disease
por: Pereira, Joana B, et al.
Publicado: (2020)

Bridging integrator 1 protein loss in Alzheimer’s disease promotes synaptic tau accumulation and disrupts tau release
por: Glennon, Elizabeth B, et al.
Publicado: (2020)

Attenuation of synaptic toxicity and MARK4/PAR1-mediated Tau phosphorylation by methylene blue for Alzheimer’s disease treatment
por: Sun, Wenchao, et al.
Publicado: (2016)

Phosphorylated tau as a toxic agent in synaptic mitochondria: implications in aging and Alzheimer’s disease
por: Torres, Angie K., et al.
Publicado: (2022)

Ten Years of Tau-Targeted Immunotherapy: The Path Walked and the Roads Ahead
por: Novak, Petr, et al.
Publicado: (2018)

Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer’s disease brain
por: Kurbatskaya, Ksenia, et al.
Publicado: (2016)

CSF GAP-43 as a biomarker of synaptic dysfunction is associated with tau pathology in Alzheimer’s disease
por: Qiang, Qiang, et al.
Publicado: (2022)

Perivascular spaces are associated with tau pathophysiology and synaptic dysfunction in early Alzheimer’s continuum
por: Vilor-Tejedor, Natalia, et al.
Publicado: (2021)

3D MALDI mass spectrometry imaging reveals specific localization of long-chain acylcarnitines within a 10-day time window of spinal cord injury
por: Quanico, Jusal, et al.
Publicado: (2018)

Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum
por: Milà‐Alomà, Marta, et al.
Publicado: (2020)

Advances in the Pathogenesis of Alzheimer’s Disease: Focusing on Tau-Mediated Neurodegeneration
por: Duan, Yale, et al.
Publicado: (2012)

Calpain-mediated tau fragmentation is altered in Alzheimer’s disease progression
por: Chen, Hsu-Hsin, et al.
Publicado: (2018)

Detection of Periodontal Pathogens from Dental Plaques of Dogs with and without Periodontal Disease
por: Kačírová, Jana, et al.
Publicado: (2022)

Extracellular Forms of Aβ and Tau from iPSC Models of Alzheimer’s Disease Disrupt Synaptic Plasticity
por: Hu, Neng-Wei, et al.
Publicado: (2018)

A novel bio-inspired strategy to prevent amyloidogenesis and synaptic damage in Alzheimer’s disease
por: Catania, Marcella, et al.
Publicado: (2022)

P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease
por: Farmer, Kathleen M., et al.
Publicado: (2020)

Evaluation of a novel immunoassay to detect p-tau Thr217 in the CSF to distinguish Alzheimer disease from other dementias
por: Hanes, Jozef, et al.
Publicado: (2020)

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
por: Bakota, Lidia, et al.
Publicado: (2016)

Microglia display modest phagocytic capacity for extracellular tau oligomers
por: Majerova, Petra, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6n225dismks057aad5j2rcin32